What is the Org number of Prostatype Genomics AB?

Prostatype Genomics AB is registered with Bolagsverket / SCB under Org 5567260285.

What is the revenue of Prostatype Genomics AB?

Prostatype Genomics AB reported revenue of SEK 199K in 2024.

Karl Fredrik Rickman is the CEO of Prostatype Genomics AB, in role since 2020.

Sven Anders Liljeblad chairs the board of Prostatype Genomics AB, in role since 2020.

Prostatype Genomics AB's registered address is Augustendalsvägen 20.

ABActive

Org 5567260285Augustendalsvägen 20, 131 52 Nacka StrandResearch and experimental development on natural sciences and engineering· NACE 7210Est. 2007 · 19 years old5-9 employees

Actively employed in the business

Name	Role	Member since
Current (3)
JK John Kjell Joakim Söderin Chief Auditor	Chief Auditor	2022
KF Karl Fredrik Rickman Chief Executive Officer	Chief Executive Officer	2020
LA Lars Anders Koch External Signatory	External Signatory	2024
Former (1)
LA Lars Anders Meyer Chief Auditor	Chief Auditor	2020 – 2022

Non-executive oversight

Name	Role	Member since
Current (6)
AB Anders Bo Folke Garibaldi Lundberg Board of Directors	Board of Directors	2020
BH Bengt Håkan Englund Board of Directors	Board of Directors	2020
MV Mattias Viktor Prage Board of Directors	Board of Directors	2022
SA Sven Anders Liljeblad Chairman	Chairman	2020
CJ Carl Jörgen Dahlström Board of Directors	Board of Directors	2023
JM Jan Michael Häggman Board of Directors	Board of Directors	2020
Former (5)
PH Per Henrik Nilsson Board of Directors	Board of Directors	2020 – 2023
JF Johan Fredrik Waldhe Board of Directors	Board of Directors	2024 – 2025
CP Christoph Petry Board of Directors	Board of Directors	2020 – 2022
KS Karlheinz Schmelig Board of Directors	Board of Directors	2022 – 2023
CL Chunde Li Board of Directors	Board of Directors	2020 – 2021

As of last annual report

No shareholder data available.

Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.